Research AppraisalSystematic Review

Instruments for measuring parents' vaccine hesitancy towards their children based on the COSMIN guidelines: A systematic review

VaccineCao, Ting, Chen, Bin, Chen, Shi et al.11 July 2026DOI

Clinical Snapshot

80CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationParents of children aged 0–18 years across any setting or country
I — InterventionVaccine hesitancy assessment instruments (questionnaires, scales, surveys) designed for parental populations
C — ComparatorNo single comparator; instruments compared against each other and against COSMIN methodological standards for measurement properties
O — OutcomesMeasurement properties of instruments including content validity, structural validity, internal consistency, cross-cultural validity/measurement invariance, reliability, measurement error, criterion validity, construct validity (hypothesis testing), and responsiveness; certainty of evidence graded via modified GRADE; COSMIN Category A/B/C recommendations

Bottom Line

This COSMIN-compliant systematic review is the first to rigorously evaluate the measurement properties of vaccine hesitancy instruments designed for parents of children aged 0–18 years. Across 40 studies and 31 instruments, three tools — the Malay-modified vaccine hesitancy scale (MVHS-M), the Vietnamese parent attitudes about childhood vaccines survey (PACV-Viet), and the parental attitude scale towards vaccination (PASV) — achieved Category A recommendation, indicating sufficient evidence of adequate measurement properties for research and clinical use. Four instruments (GVHS, VAX, VAI, VBAT) received Category C, suggesting insufficient or inadequate evidence. The review is methodologically sound, with PROSPERO registration, COSMIN Risk of Bias assessment, and modified GRADE certainty ratings. Key limitations include underreported measurement error and responsiveness data across the primary literature, and the language-specific nature of two Category A instruments. For Australian clinicians and public health practitioners, the PASV offers the most broadly applicable option, while MVHS-M and PACV-Viet are valuable for culturally and linguistically diverse communities. Future research should prioritise longitudinal validation and cross-cultural adaptation of Category A instruments to strengthen their utility across diverse healthcare settings.

Evidence: Moderate

Key Findings

  • P Value: Not reported; COSMIN methodology uses qualitative evidence synthesis rather than p-value-based inference

  • Effect Size: Category A recommendation (sufficient evidence of adequate measurement properties): MVHS-M (Malay version of the modified vaccine hesitancy scale), PACV-Viet (Vietnamese version of the parent attitudes about childhood vaccines survey), and PASV (parental attitude scale towards vaccination). Category C recommendation: GVHS, VAX, VAI, VBAT. Remaining instruments: Category B.

  • Primary Outcome: COSMIN-graded measurement properties of 31 vaccine hesitancy assessment instruments for parents of children aged 0–18 years

  • Nnt Or Sensitivity: Not applicable for a measurement properties review; relevant metrics are reliability coefficients, validity indices, and GRADE certainty ratings reported in the full text

  • Confidence Interval: Not applicable in conventional meta-analytic sense; certainty of evidence assessed via modified GRADE system

Clinical Application

Category A instruments are feasible for use in clinical and research settings, subject to language and cultural appropriateness. The COSMIN framework provides a transparent basis for instrument selection. Clinicians should note that measurement error and responsiveness data remain limited for all recommended instruments, which may affect their use in longitudinal monitoring or intervention evaluation contexts. Australia's multicultural population includes substantial Malay-speaking (Malaysian and Indonesian communities) and Vietnamese-speaking communities, making the MVHS-M and PACV-Viet potentially relevant for targeted community health programs. The PASV, as a general parental attitude scale, may have broader applicability across Australian primary care and immunisation clinic settings. The RACGP supports evidence-based approaches to addressing vaccine hesitancy in primary care (RACGP Standards for General Practices; National Immunisation Program context). The TGA and ATAGI do not currently mandate specific vaccine hesitancy measurement tools, but this review provides an evidence base for selecting validated instruments in quality improvement, research, and public health surveillance activities. The Australian Immunisation Register (AIR) tracks coverage but does not capture hesitancy attitudes; validated instruments identified here could complement AIR data in population health research. PBS and TGA considerations are not directly applicable to instrument selection but are relevant to the vaccines being assessed for hesitancy. Parents of children aged 0–18 years in clinical, public health, and research settings where vaccine hesitancy assessment is required. Most directly applicable to populations similar to those in which Category A instruments were validated (Malay-speaking and Vietnamese-speaking communities; general parental populations for PASV).

Abstract

BACKGROUND: Parental vaccine hesitancy undermines immunization gains, leading to resurgent outbreaks and increased child mortality. Reliable assessment instruments are urgently needed to guide effective interventions and improve coverage. Despite multiple vaccine hesitancy assessment instruments, no systematic reviews have evaluated the measurement properties of these instruments against established methodological standards, limiting evidence-based selection. OBJECTIVE: To systematically evaluate the methodological quality and measurement properties of vaccine hesitancy assessment instruments for parents of 0-18 children, providing an evidence-based basis for selecting appropriate instruments. DESIGN: Measurement properties are systematically reviewed according to the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. METHODS: Six electronic databases were systematically searched from inception until July 15, 2025. Methodological quality was assessed using the COSMIN Risk of Bias Checklist and measurement properties were synthesized according to the COSMIN criteria. A modified Grading, Recommendations, Assessment, Development, and Evaluation system was used to assess the certainty of evidence. RESULTS: Forty studies evaluating 31 vaccine hesitancy assessment instruments were included. Based on COSMIN evidence grading, the Malay version of the modified vaccine hesitancy scale (MVHS-M), the Vietnamese version of the parent attitudes about childhood vaccines survey (PACV-Viet), and the parental attitude scale towards vaccination (PASV) received Category A recommendation. The general vaccine hesitancy scale (GVHS), vaccination attitudes examination (VAX), vaccine acceptance instrument (VAI), and vaccine barriers assessment tool (VBAT) received Category C recommendation, while others were Category B recommendation. CONCLUSIONS: This systematic review identified MVHS-M, PACV-Viet, and PASV as effective tools for assessing vaccine hesitancy in parents, suitable for both research and clinical use. Future research should comprehensively assess their measurement properties, especially exploring measurement error and responsiveness. REGISTRATION: A protocol was registered on the PROSPERO (CRD420251070194).

References

  1. 1.Cao, T., Chen, B., Chen, S., Liu, H., Li, Y., Ren, X., Gao, J., & Hou, C. (2026). Instruments for measuring parents' vaccine hesitancy towards their children based on the COSMIN guidelines: A systematic review. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128703
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service